Therapeutic breakthroughs in neuromodulation merge wearable technologies, deep brain implants, and tailored stimulations ...

Predicting who will transition from acute to chronic pain is the “holy grail” of pain neuroscience. A novel biomarker ...

Kevin Hill, 65, used to suffer sleepless nights due to his harrowing Parkinson's disease symptoms. Now, he forgets about his ...

In 2017 he visited his GP and was diagnosed with Parkinson's. He was told there were medicines but no cure, but there was a ...

If you’re rooting for a sweet mix of growth and dividends, these four US stocks should be on your radar. The post 4 Reputable ...

The healthcare IT market is driving digital transformation by enhancing efficiency, addressing workforce shortages, and ...

MRI-guided Neurosurgical Ablation Market Rising Demand for Minimally Invasive Procedures and Advanced Imaging Technologies <a target=_blan ...

Newcastle's Royal Victoria Infirmary is one of only four hospitals worldwide to offer a new high-tech Parkinson's treatment.

Advancements in non-opioid therapies, AI-integrated solutions, and regenerative medicine drive transformative growth in the pain management market. AUSTIN, TX, UNITED STATES, January 21, 2025 ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

DBS may declare a special dividend of S$0.50 a share for the fourth quarter of FY2024 as well as raise its ordinary dividend per share to S$0.60, said CGS International in a report on Tuesday (Jan 14) ...